Agile Therapeutics, Inc. 0AL.F Stock
Agile Therapeutics, Inc. Price Chart
Agile Therapeutics, Inc. 0AL.F Financial and Trading Overview
| Agile Therapeutics, Inc. stock price | 7.24 EUR |
| Previous Close | 7.24 EUR |
| Open | 7.24 EUR |
| Bid | 0 EUR x N/A |
| Ask | 0 EUR x N/A |
| Day's Range | 7.24 - 7.24 EUR |
| 52 Week Range | 7.24 - 128 EUR |
| Volume | N/A |
| Avg. Volume | 1 EUR |
| Market Cap | 8.16M EUR |
| Beta (5Y Monthly) | 1.144366 |
| PE Ratio (TTM) | 0.07671364 |
| EPS (TTM) | 92.79 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0AL.F Valuation Measures
| Enterprise Value | 4.95M EUR |
| Trailing P/E | 0.07671364 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.63086146 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 0.383 |
| Enterprise Value/EBITDA | -0.157 |
Trading Information
Agile Therapeutics, Inc. Stock Price History
| Beta (5Y Monthly) | 1.144366 |
| 52-Week Change | -87.51% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 128 EUR |
| 52 Week Low | 7.24 EUR |
| 50-Day Moving Average | 7.61 EUR |
| 200-Day Moving Average | 11 EUR |
0AL.F Share Statistics
| Avg. Volume (3 month) | 1 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 1.13M |
| Float | 988.41K |
| Short Ratio | N/A |
| % Held by Insiders | 0.0040% |
| % Held by Institutions | 3.53% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -157.83% |
| Operating Margin (ttm) | -251.77% |
| Gross Margin | 43.47% |
| EBITDA Margin | -243.73% |
Management Effectiveness
| Return on Assets (ttm) | -94.68% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 12.94M EUR |
| Revenue Per Share (ttm) | 20.07 EUR |
| Quarterly Revenue Growth (yoy) | 116.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | -31530000 EUR |
| Net Income Avi to Common (ttm) | -20417000 EUR |
| Diluted EPS (ttm) | 94.39 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.43M EUR |
| Total Cash Per Share (mrq) | 4.48 EUR |
| Total Debt (mrq) | 2.22M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.589 |
| Book Value Per Share (mrq) | -10.121 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -22791000 EUR |
| Levered Free Cash Flow (ttm) | -9467750 EUR |
Profile of Agile Therapeutics, Inc.
| Country | Germany |
| State | NJ |
| City | Princeton |
| Address | 500 College Road East |
| ZIP | 08540 |
| Phone | 609 683 1880 |
| Website | https://www.agiletherapeutics.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 22 |
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. The company was incorporated in 1997 and is headquartered in Princeton, New Jersey.
Q&A For Agile Therapeutics, Inc. Stock
What is a current 0AL.F stock price?
Agile Therapeutics, Inc. 0AL.F stock price today per share is 7.24 EUR.
How to purchase Agile Therapeutics, Inc. stock?
You can buy 0AL.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Agile Therapeutics, Inc.?
The stock symbol or ticker of Agile Therapeutics, Inc. is 0AL.F.
Which industry does the Agile Therapeutics, Inc. company belong to?
The Agile Therapeutics, Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Agile Therapeutics, Inc. have in circulation?
The max supply of Agile Therapeutics, Inc. shares is 2.96M.
What is Agile Therapeutics, Inc. Price to Earnings Ratio (PE Ratio)?
Agile Therapeutics, Inc. PE Ratio is 0.07803643 now.
What was Agile Therapeutics, Inc. earnings per share over the trailing 12 months (TTM)?
Agile Therapeutics, Inc. EPS is 92.79 EUR over the trailing 12 months.
Which sector does the Agile Therapeutics, Inc. company belong to?
The Agile Therapeutics, Inc. sector is Healthcare.